Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
- Conditions
- Breast CancerColorectal CancerOvarian Cancer
- Interventions
- Behavioral: Genetic Testing and CounselingBehavioral: Screening Form
- Registration Number
- NCT05649072
- Lead Sponsor
- M.D. Anderson Cancer Center
- Brief Summary
Identifying women at risk for hereditary cancer potentiates prevention, early detection or personalised treatment against cancer. We using mobile mammography units will provide genetic sceening and testing services to underserved women coming for thier mammograms to these units.
- Detailed Description
Objectives:
1. To identify underserved women at risk for hereditary breast and colorectal cancers and would be eligible for standard of care genetic counseling and testing using national screening guidelines.
2. To provide education to providers and patients regarding hereditary cancers using previously IRB approved educational material and short video.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 1000
Any woman scheduled at Project VALET mammography screening mobile units will be eligible for this study.
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Genetic Testing and Counseling Genetic Testing and Counseling Participants will be given a saliva collection kit to collect a saliva sample for hereditary cancer and genetic testing. The kit includes all standard paperwork and instructions for collecting the sample and shipping the kit back to the genetic testing company (Invitae). Screening Form Screening Form Participants will complete a screening form to assess your risk of hereditary breast and colorectal cancers.
- Primary Outcome Measures
Name Time Method To identify underserved women at risk for hereditary breast and colorectal cancers eligible for standard-of-care genetic counseling using national screening guidelines. through study completion; an average of 1 year.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
M D Anderson Cancer Center
🇺🇸Houston, Texas, United States